Evidence map›Paper›PMID 42733511›Full record

ArticleJSES reviews, reports, and techniques2026

Clinical and radiographic outcomes following medial collateral ligament-sparing interposition elbow arthroplasty using acellular dermal allograft.

Tyler M Staten, Randall A Arroyo, Sierra J Casper, Christopher D Joyce, Peter N Chalmers, Robert Z Tashjian

Abstract read
In one paragraph

Article in JSES reviews, reports, and techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tyler M StatenDepartment of Orthopaedics, University of Utah, Salt Lake City, UT, USA.
Randall A ArroyoDepartment of Orthopaedics, University of Utah, Salt Lake City, UT, USA.
Sierra J CasperDepartment of Orthopaedics, University of Utah, Salt Lake City, UT, USA.
Christopher D JoyceDepartment of Orthopaedics, University of Utah, Salt Lake City, UT, USA.
Peter N ChalmersDepartment of Orthopaedics, University of Utah, Salt Lake City, UT, USA.
Robert Z TashjianDepartment of Orthopaedics, University of Utah, Salt Lake City, UT, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Interposition arthroplasty is a joint-preserving option for younger patients with elbow osteoarthritis who are poor candidates for total elbow arthroplasty. However, optimal graft choice and surgical technique remain unclear. This study evaluates clinical and radiographic outcomes following interposition elbow arthroplasty using an acellular dermal allograft with a medial collateral ligament-sparing approach. Methods: A retrospective review was performed of consecutive patients undergoing interposition elbow arthroplasty at a single academic institution from 2014 to 2025. Patients with ≥6 months' follow-up were included. Outcomes included visual analog scale pain, Disabilities of the Arm, Shoulder, and Hand scores, range of motion, radiographic joint space, complications, and reoperations. Subgroup analyses were performed by diagnosis and revision status. Radiographic outcomes were analyzed using repeated measures analysis of variance. Results: Eighteen patients (mean age, 54 years) were included, with a mean follow-up of 40 (6-87) months for patient-reported outcomes. Significant improvements were observed in visual analog scale pain (-3.0, Conclusion: Interposition elbow arthroplasty using an acellular dermal allograft with a medial collateral ligament-sparing approach yields improvements in pain and function that reach a minimally clinically important difference. Patients undergoing revision or secondary surgery experienced very high rates of complication or reoperation, while those undergoing primary surgery did not. Despite partial loss of early radiographic gains, the procedure does not appear to accelerate degenerative changes, supporting its role as a joint-preserving option in younger patients.

Indexed as

Dermal allograftInterposition elbow arthroplastyLigament sparingOsteoarthritisPosttraumatic arthritisRevision

Identifiers

PMID42733511
PMCPMC13571405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.